CX Institutional’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$338K Sell
647
-10
-2% -$5.48K 0.01% 587
2026
Q2
$346K Buy
657
+12
+2% +$6.73K 0.01% 577
2026
Q1
$362K Sell
645
-25
-4% -$16K 0.01% 543
2025
Q4
$453K Buy
670
+32
+5% +$21.8K 0.01% 449
2025
Q3
$408K Sell
638
-10
-2% -$6.07K 0.01% 484
2025
Q2
$348K Buy
648
+135
+26% +$64.6K 0.01% 463
2025
Q1
$215K Buy
+513
New +$223K 0.01% 583
2024
Q2
– Sell
-406
Closed -$219K – 554
2024
Q1
$219K Sell
406
-5
-1% -$2.73K 0.01% 517
2023
Q4
$228K Buy
+411
New +$193K 0.01% 462
2022
Q3
– Sell
-158
Closed -$56K – 780
2022
Q2
$56K Buy
+158
New +$64.4K ﹤0.01% 653
2021
Q4
– Sell
-125
Closed -$78K – 606
2021
Q3
$78K Sell
125
-5
-4% -$3.36K 0.01% 492
2021
Q2
$82K Buy
130
+21
+19% +$11.6K 0.01% 472
2021
Q1
$53K Buy
109
+6
+6% +$3.01K ﹤0.01% 482
2020
Q4
$51K Buy
103
+30
+41% +$13.4K ﹤0.01% 435
2020
Q3
$29K Buy
73
+11
+18% +$4.07K ﹤0.01% 478
2020
Q2
$20K Buy
62
+54
+675% +$15.6K ﹤0.01% 440
2020
Q1
$2K Sell
8
-13
-62% -$3.39K ﹤0.01% 672
2019
Q4
$5K Hold
21
– – ﹤0.01% 547
2019
Q3
$6K Buy
+21
New +$5.84K ﹤0.01% 546
2019
Q2
– Sell
-16
Closed -$4K – 970
2019
Q1
$4K Buy
+16
New +$3.3K ﹤0.01% 591

Other funds holding IDXX

CX Institutional's IDXX Position: Q3 2026 in Review

CX Institutional reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q3 2026, selling an estimated $5.48K and leaving 647 shares worth $338K. The position accounts for 0.01% of the portfolio, ranked #587.

CX Institutional first reported a position in IDXX in Q1 2019 and has held it in 20 quarters since. The position peaked at $453K in Q4 2025. 300 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • CX Institutional held 647 shares of Idexx Laboratories worth $338K as of Q3 2026.
  • CX Institutional sold 10 Idexx Laboratories shares in Q3 2026, an estimated $5.48K.
  • Idexx Laboratories made up 0.01% of CX Institutional's portfolio in Q3 2026, its #587 holding.
  • CX Institutional first reported a position in Idexx Laboratories in Q1 2019 and has held it in 20 quarters since.
  • CX Institutional's Idexx Laboratories position peaked at $453K in Q4 2025.
  • 300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.